Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

0.971
Delayed Data
As of May 27
 -0.019 / -1.92%
Today’s Change
0.64
Today|||52-Week Range
7.32
-33.03%
Year-to-Date
There Are Crazy Valuations, and Then There Are the Valuations of These 3 Stocks
May 23 / MotleyFool.com - Paid Partner Content
Better Buy: MannKind Corp. vs. Dexcom
May 20 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close0.99
Today’s open0.99
Day’s range0.96 - 1.01
Volume3,207,407
Average volume (3 months)6,267,894
Market cap$463.8M
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+74.18%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ENTAEnanta Pharmaceutica...+1.20+5.17%
RPTPRaptor Pharmaceutica...+0.33+6.53%
VNDAVanda Pharmaceutical...+1.12+11.80%
XNPTXenoport Inc+0.02+0.28%
Data as of 3:59pm ET, 05/27/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts

Partner Offers

Search for Jobs